170 related articles for article (PubMed ID: 31175988)
1. Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion.
Guan J; Huan X; Liu Q; Jin L; Wu H; Zhang X; Mao S
Int J Pharm; 2019 Jul; 566():594-603. PubMed ID: 31175988
[TBL] [Abstract][Full Text] [Related]
2. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of Soluplus and hyaluronic acid on the supersaturation maintenance of lovastatin: The facilitated in vitro-in vivo performance and improved physical stability.
Guan J; Liu Q; Jin L; Xu H; Wu H; Zhang X; Mao S
Carbohydr Polym; 2019 Oct; 222():114978. PubMed ID: 31320056
[TBL] [Abstract][Full Text] [Related]
4. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
Lee DH; Yeom DW; Song YS; Cho HR; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2015 Jan; 478(1):341-347. PubMed ID: 25437113
[TBL] [Abstract][Full Text] [Related]
5. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
6. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro/in vivo Evaluation of Lacidipine by Adsorption onto Fumed Silica Using Supercritical Carbon Dioxide.
Geng Y; Fu Q; Guo B; Li Y; Zhang X; Wang X; Zhang T
Curr Drug Deliv; 2016; 13(7):1053-1064. PubMed ID: 26634790
[TBL] [Abstract][Full Text] [Related]
8. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
9. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.
Quan G; Niu B; Singh V; Zhou Y; Wu CY; Pan X; Wu C
Int J Nanomedicine; 2017; 12():8801-8811. PubMed ID: 29263669
[TBL] [Abstract][Full Text] [Related]
10. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
Paulus F; Holm R; Stappaerts J; Bauer-Brandl A
Eur J Pharm Sci; 2024 Jun; 197():106765. PubMed ID: 38608735
[TBL] [Abstract][Full Text] [Related]
11. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
12. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study.
Fares AR; ElMeshad AN; Kassem MAA
Drug Deliv; 2018 Nov; 25(1):132-142. PubMed ID: 29275642
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of dissolution and oral bioavailability by adjusting microenvironment pH in crocetin ternary solid dispersions: Optimization, characterization, in vitro evaluation, and pharmacokinetics.
Tong Z; Liu X; Tao Y; Feng P; Luan F; Jie X; Xie Z; Pu F; Xu Z; Wang P
Drug Deliv Transl Res; 2024 Jul; 14(7):1923-1939. PubMed ID: 38117406
[TBL] [Abstract][Full Text] [Related]
15. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs-The Case of Alpha-Mangostin.
Budiman A; Citraloka ZG; Muchtaridi M; Sriwidodo S; Aulifa DL; Rusdin A
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365204
[TBL] [Abstract][Full Text] [Related]
17. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
[TBL] [Abstract][Full Text] [Related]
18. The baicalein amorphous solid dispersion to enhance the dissolution and bioavailability and effects on growth performance, meat quality, antioxidant capacity and intestinal flora in Taihang chickens.
Gao J; Fan Y; Lu C; Zhao X; He X
Poult Sci; 2024 Jul; 103(7):103768. PubMed ID: 38703758
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique.
Ha ES; Baek IH; Cho W; Hwang SJ; Kim MS
Chem Pharm Bull (Tokyo); 2014; 62(6):545-51. PubMed ID: 24881660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
